Here are five things to know about the transaction:
• Mr. Widensohler sold 50,000 shares of the stock on the open market.
• Average price for the stock was $37.73.
• The total transaction was valued at around $1.88 million.
• Mr. Widensholer now owns 365,596 shares valued at $13.79 million.
• The transaction took place on March 10.
Today LDR opened at $37.99 and has a market cap at just more than $1 billion. Zacks recently downgraded LDR to “neutral” and set the price target at $38.60 but Brean Capital, which initiated coverage on LDR Feb. 23, set the share rating at “buy” with a $50 target price.
More articles on orthopedic devices:
LDR CEO sells 38k+ shares—5 things to know
Piper Jaffray assumes Integra LifeSciences coverage—5 things to know
Zimmer sells $7.65B of senior notes for Biomet merger—7 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
